Skip to content
Company Analysis

PAVmed Inc. PAVM

A comprehensive view of key metrics, scores, and financial health for PAVmed Inc.

Overview of PAVmed Inc.

PAVM NCM
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Micro Cap
PAVmed Inc. (PAVM), is a Micro Cap company, in the Medical Devices industry, last closed at $2.26, about 0.0% overvalued vs fair value, -82.6% 1Y return, ranked 862/1145 in sector.
Metrics Rev Growth -97.6% ROE 2.6% Gross Margin -207.0%
USD 2.26
4.15%
(Delayed)
• Vol 90d: 103.6%
52-Week Range
Market Cap
$17.40M
Enterprise Value
$16.82M
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Fair
Health
Weak
Efficiency
Weak
Valuation
Weak
Growth
Good
Profitability
Fair
Health
Weak
Efficiency
Weak
Valuation
Weak
Completeness: 82%
Confidence: 88%
Updated: Oct 24
Top Beats

Quick Facts

Website https://www.pavmed.com
HQ New York, NY
Employees 39
Fiscal year Dec 31

Next Events

Earnings Nov 12

Fair Value Snapshot

Bear Base Bull
$0
$0
$0
Current: $2.26

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$71.0K
-97.6%%
Gross Profit
-$147.0K
92%%
Operating Income (GAAP)
-$21.8M
51%%
EBITDA
-$2.3M
-107.9%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
-207.0%
Poor

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
3
Active Leaks
1/3
Improving
0
High Impact
3
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating PAVmed Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
15
/100
Weak
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Above-Peer Asset Productivity Asset productivity is strong vs peers (score 0.78). Above-peer ROA underpins the growth durability narrative.

Key risks

  • Below-Peer Gross Margins Gross margin quality lags peers (score 0.04). May indicate commodity-like product mix or distributor margin drag.
  • Weak FCF Generation FCF margin quality lags peers (score 0.06). Below-peer FCF conversion is a MedTech quality warning.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Weak
4
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 95% Coverage
Trade-Off Triangle Visualization A ternary plot showing PAVM's balance between Growth (31.6%), Profitability (19.0%), and Safety (49.5%). Growth 32% Safety 49% Profitability 19%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

21th percentile vs peers
22
Key Signals
TSR 215.84 99p Asset Growth YoY 26.6% 86p EPS Growth YoY -1.05 10p Rev Growth YoY -97.6% 4p Revenue CAGR 3Y -42.7% 4p
Strengths
  • TSR in top 20% of peers (215.84, 99th percentile)
Risks
  • EPS Growth YoY in bottom 20% of peers (-1.05)
  • Rev Growth YoY in bottom 20% of peers (-97.6%)

Profitability

13th percentile vs peers
13
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

34th percentile vs peers
34
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for PAVmed Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$-0.44
- - -
- upside
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000